SANDOZ GROUP AG by Sandoz Group AG Financials - Benzinga

SANDOZ GROUP AG by Sandoz Group AG

SDZXFOTCQX

Trade with Public

Trade with Public

$89.26

-1.20-1.33%

At close: Aug 21, 5:00 PM EST

Overview NewsFinancialsSentiment Compare

SANDOZ GROUP AG by Sandoz Group AG Financials

SANDOZ GROUP AG by Sandoz Group AG (SDZXF) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Novartis Outlines Pure-Play Strategy Progress After Generics Business Spin-Off

Novartis AG (NYSE: NVS) has outlined the progress made in delivering its pure-play strategy, focused on four core therapeutic areas (Cardiovascular-Renal-Metabolic, Immunology, Neuroscience, Oncology), two plus three technology platforms (Chemistry, Biotherapeutics, xRNA, Radioligand, Gene & Cell Therapy) in four priority geographies (US, China, Germany, Japan).

Vandana Singh